Medical devices, healthcare technology and the business of care
510(k) clearance · K252795

ZeniCore Automatic Biopsy Instrument (863212100 / ZeniCore Automatic Biopsy Device 12ga x 10cm with Coaxial Introducer Kit); ZeniCore Automatic Biopsy Instrument (863212130 / ZeniCore Automatic Biopsy Device 12ga x 13cm with Coaxial Introducer Kit); ZeniCore Automatic Biopsy Instrument (863214100 / ZeniCore Automatic Biopsy Device 14ga x 10cm with Coaxial Introducer Kit); ZeniCore Automatic Biopsy Instrument (863214130 / ZeniCore Automatic Biopsy Device 14ga x 13cm with Coaxial

Argon Medical Devices, Inc. · Decision date Feb 23, 2026

FDA DECISIONK252795

What did the FDA decide?

FDA records K252795 as a 510(k) premarket notification, with a decision dated Feb 23, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Feb 23, 2026

FDA source record

Regulatory record facts

Identifier
K252795
Regulatory pathway
510(k) premarket notification
Product code
KNW
Decision code
SESE
Decision date
Feb 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Instrument, Biopsy.

Product code
KNW
FDA device class
2

FDA decision timeline

  1. K252795 received

    Application receipt date recorded by FDA.

  2. K252795 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code KNW

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Argon Medical Devices, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Athens, TX

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records